Education
About Us
Working with TipRanks
Follow Us
ELEVAI Labs Inc. (ELAB)
NASDAQ:ELAB
ELAB Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.81 - $526.40
Previous CloseN/A
Volume180.10K
Average Volume (3M)5.39M
Market Cap
$3.01M
Enterprise Value-$3.62M
Total Cash (Recent Filing)$3.98M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.67
Next Earnings
Dec 15, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.45
Shares Outstanding1,484,827
10 Day Avg. Volume16,072,315
30 Day Avg. Volume5,392,844
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap-1.20
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.72
Enterprise Value/Ebitda1.52
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ELEVAI Labs Inc. News
ELAB FAQ
What was ELEVAI Labs Inc.’s price range in the past 12 months?
ELEVAI Labs Inc. lowest stock price was $1.81 and its highest was $526.40 in the past 12 months.
What is ELEVAI Labs Inc.’s market cap?
ELEVAI Labs Inc.’s market cap is $3.01M.
When is ELEVAI Labs Inc.’s upcoming earnings report date?
ELEVAI Labs Inc.’s upcoming earnings report date is Dec 15, 2025 which is in 108 days.
How were ELEVAI Labs Inc.’s earnings last quarter?
ELEVAI Labs Inc. released its earnings results on Aug 13, 2025. The company reported -$0.452 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.452.
Is ELEVAI Labs Inc. overvalued?
According to Wall Street analysts ELEVAI Labs Inc.’s price is currently Overvalued.
Does ELEVAI Labs Inc. pay dividends?
ELEVAI Labs Inc. does not currently pay dividends.
What is ELEVAI Labs Inc.’s EPS estimate?
ELEVAI Labs Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ELEVAI Labs Inc. have?
ELEVAI Labs Inc. has 1,484,827 shares outstanding.
What happened to ELEVAI Labs Inc.’s price movement after its last earnings report?
ELEVAI Labs Inc. reported an EPS of -$0.452 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.073%.
Which hedge fund is a major shareholder of ELEVAI Labs Inc.?
Currently, no hedge funds are holding shares in ELAB
Company Description
ELEVAI Labs Inc.
ELEVAI Labs Inc. (ELAB) is a biotechnology company operating in the skincare sector. The company focuses on developing advanced skincare products that utilize exosome technology to promote skin health and rejuvenation. ELEVAI Labs aims to create clinically validated solutions that cater to both consumer and professional markets, emphasizing innovation and efficacy in their product offerings.
Technical Analysis
TNF Pharmaceuticals
―
Scinai Immunotherapeutics
―
Entero Therapeutics
―
Protagenic Therapeutics
―
ZyVersa Therapeutics
―
Ownership Overview
25.70% Insiders
0.82% Other Institutional Investors
74.30% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---